Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2023-11-14 00:00:00 ET · period of report 2023-11-11 · accession 0001367644-23-000191 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-14 | 2023-11-11 | EBS | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | F - Tax | $2.00 | -413 | 178.8K | -0.2% | -$826 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-11 | F | D | 413 | $2.00 | 178,793 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes. |